IL-6 may cross the blood–brain barrier [10], suggesting its possible involvement in neuroinflammation [11,12] and participation in the pathogenesis of depression [13,14,15] and schizophrenia [16,17]. This evidence concerns the gene IL6 and depressive symptom measurement.